2017 Speakers

Speakers

PJ Chen
Vice President, Global Clinical Development/Regulatory Affairs and President
UNITED NEUROSCIENCE TAIWAN
Billy Cho
Head of Asia Healthcare
CITIGROUP
Rebecca Dai
Head Clinical Project Management, Clinical Development Operations
BAYER HEALTHCARE
Frank Fan
Consultant on Pharmaceutical Medicine
James Garner
Chief Executive Officer
NOVOGEN
Tong Guo
Head of Biostatistics, South Africa & Asia
QUINTILES
Ye Hua
Senior Vice President, Head Clinical Development & Regulatory Affairs
HUTCHISON MEDIPHARMA
Min Irwin
Venture Partner
QIMING VENTURE PARTNERS
Ming Ji
Vice President, Global Drug Safety Evaluation
MITSUBISHI TANABE PHARMA AMERICA
Frank Jiang
Chief Executive Officer
CSTONE PHARMA
Helen Jiang
Senior Vice President & Chief Medical Officer
QINGFENG MEDICINE
Yue Kang
China Development Director
ABBVIE
Howe Li
Chief Medical Officer / Chief Executive Officer
TIGERMED CONSULTING / TIGERMED-INTELLIPV
Qing Li
Senior Director, OTC, Medical Affairs
JOHNSON & JOHNSON
Joalin Lim
Managing Director
AGAPE LIFE SYSTEM SUPPORT
Jay Mei
Chief Executive Officer
ANTENGENE CORPORATION
Cindy Ru
Executive Vice President, Chief Scientific Officer
CARSGEN THERAPEUTICS
Joan Shen
Vice President, Development Head China R&D and Medical Affairs
JANSSEN PHARMACEUTICAL
Tetsuomi Takano
Senior Strategy Director, Operational Strategy & Planning
COVANCE
Jingsong Wang
Chief Executive Officer
HARBOUR BIOMED
Jonathan Wang
Senior Managing Director
ORBIMED
Yan Wu
Head of Clinical Operations and Drug Safety
HUTCHISON MEDIPHARMA
Crystal Xu
Senior Director and Head of Clinical Development
CANBRIDGE PHARMA
Jason Yang
Chief Medical Officer
CSTONE PHARMACEUTICALS
Annie Yin
Senior Regulatory Affairs Director
JOHNSON & JOHNSON
Dan Zhang
Executive Chairman
FOUNTAIN MEDICAL DEVELOPMENT
Fangning Zhang
Partner
MCKINSEY & COMPANY
Sean Zhao
Head of US Patient Safety Surveillance, US Medical Affairs
ASTRAZENECA